Form 4: Sanara MedTech COO's Tax Withholding on Vesting Shares

Sanara MedTech's Chief Operating Officer, Jacob A. Waldrop, reported a disposition of 714 common shares to cover tax obligations related to restricted stock vesting.

Summary

• Jacob A. Waldrop, Chief Operating Officer of Sanara MedTech Inc. (SMTI), reported a transaction on February 25, 2026.
• The transaction involved the disposition of 714 shares of SMTI common stock at a price of $19.9 per share.
• These shares were withheld by Sanara MedTech Inc. to satisfy tax withholding obligations.
• The tax obligations arose from the annual vesting of 2,930 shares of restricted stock previously granted to Mr. Waldrop.
• No shares were actually issued or sold by Mr. Waldrop in this specific transaction; it was a tax-related withholding.
• Following this transaction, Mr. Waldrop beneficially owns 10,799 shares of common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the routine vesting of executive equity compensation and the associated tax withholding, which is a standard administrative process.

Positives

• The transaction represents a routine tax withholding event, not an open market sale by the insider.
• The underlying event is the vesting of 2,930 restricted stock shares, indicating a successful milestone for the executive's compensation plan.

Negatives

• No direct negatives are identified from this routine tax withholding transaction.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider filings like Form 4, particularly those related to tax withholdings on vesting equity, are common across all industries as part of executive compensation plans. This specific filing for Sanara MedTech Inc. (SMTI) reflects standard practice for equity-based incentives in the healthcare technology sector.

Comparison to Industry Standards

• The withholding of shares to cover tax liabilities upon restricted stock vesting is a standard practice for executive compensation across publicly traded companies, aligning with common industry benchmarks for equity incentive plans.

Related Party Transactions

• The withholding of 714 shares by Sanara MedTech Inc. from Chief Operating Officer Jacob A. Waldrop to cover tax obligations related to restricted stock vesting is a standard related-party transaction for executive compensation.

Stakeholder Impact

• Shareholders: The transaction is a routine administrative event related to executive compensation and does not indicate a change in the company's operational or financial performance.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding event related to the vesting of restricted stock for a company executive. It does not provide new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the fundamental investment thesis remains unchanged.

Keywords

Sanara MedTech, SMTI, Jacob A. Waldrop, Form 4, insider transaction, stock vesting, tax withholding, restricted stock, beneficial ownership